Anti-Müllerian Hormone and Cardiometabolic Disease in Women: A Two-Sample Mendelian Randomization Study

Anti-Müllerian Hormone and Cardiometabolic Disease in Women: A Two-Sample Mendelian Randomization Study

Background: Higher age-specific circulating anti-Müllerian hormone (AMH) levels have been linked to a lower risk of cardiometabolic outcomes. However, whether AMH has a casual role in the etiology of these diseases is unknown. The objective of this study was therefore to explore if circulating AMH l...

Full description

Bibliographic Details
Main Authors: Renée M.G. Verdiesen, Joanna von Berg, M. Abdullah Said, Pim van der Harst, Anubha Mahajan, Carla H. van Gils, Yvonne T. van der Schouw, N. Charlotte Onland-Moret
Format: Article
Language:English
Published: IMR Press 2022-07-01
Series:Reviews in Cardiovascular Medicine
Subjects:
anti-müllerian hormone
amh
coronary artery disease
stroke
type 2 diabetes
mendelian randomization
women
Online Access:https://www.imrpress.com/journal/RCM/23/8/10.31083/j.rcm2308269

Internet

https://www.imrpress.com/journal/RCM/23/8/10.31083/j.rcm2308269

Similar Items